Myovant Sciences Total Liabilities 2017-2022 | MYOV

Myovant Sciences total liabilities from 2017 to 2022. Total liabilities can be defined as the total value of all possible claims against the corporation.
Myovant Sciences Annual Total Liabilities
(Millions of US $)
2022 $993
2021 $1,079
2020 $214
2019 $169
2018 $81
2017 $19
2016 $0
Myovant Sciences Quarterly Total Liabilities
(Millions of US $)
2022-03-31 $993
2021-12-31 $1,037
2021-09-30 $1,062
2021-06-30 $1,127
2021-03-31 $1,079
2020-12-31 $1,045
2020-09-30 $336
2020-06-30 $261
2020-03-31 $214
2019-12-31 $178
2019-09-30 $167
2019-06-30 $171
2019-03-31 $169
2018-12-31 $155
2018-09-30 $94
2018-06-30 $94
2018-03-31 $81
2017-12-31 $56
2017-09-30 $17
2017-06-30 $17
2017-03-31 $19
2016-12-31 $8
2016-09-30 $40
2016-06-30 $9
2016-03-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.264B $0.231B
Myovant Sciences Ltd. is a biopharmaceutical company. It focused on developing and commercializing therapies for women's health diseases and other endocrine-related disorders, including advanced prostate cancer. The company's product candidate consists of relugolix which are in clinical trial, an oral once-daily small molecule that acts as a gonadotropin-releasing hormone receptor antagonist. Myovant Sciences Ltd. is based in Hamilton, Bermuda.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $168.111B 10.23
Bio-Rad Laboratories (BIO.B) United States $14.121B 30.63
QIAGEN (QGEN) Netherlands $10.588B 16.71
Biohaven Pharmaceutical Holding (BHVN) United States $10.141B 0.00
Ginkgo Bioworks Holdings (DNA) United States $5.081B 0.00
Arcus Biosciences (RCUS) United States $1.832B 46.46
Emergent Biosolutions (EBS) United States $1.646B 7.05
Zymeworks (ZYME) Canada $0.364B 0.00
Gelesis Holdings (GLS) United States $0.116B 0.00
Ambrx Biopharma (AMAM) United States $0.111B 0.00
Enzo Biochem (ENZ) United States $0.102B 0.00
SQZ Biotechnologies (SQZ) United States $0.099B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00